Reply - 05/08/20
Doi : 10.1016/j.jaci.2020.05.026
Lu Qin, PhD a, b, Cong Zhang, MD a, b, Junqing Yue, MD a, b, Min Xie, MD a, b 
a Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
b Key Laboratory of Respiratory Diseases, National Ministry of Health of the People’s Republic of China and National Clinical Research Center for Respiratory Disease, Wuhan, China
Il testo completo di questo articolo è disponibile in PDF.
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2020
American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 146 - N° 2
P. 335-336 - agosto 2020 Ritorno al numero
Articolo precedente
- Prevalence of comorbid asthma in COVID-19 patients
- Marcus W. Butler, Aoife O’Reilly, Eleanor M. Dunican, Patrick Mallon, Eoin R. Feeney, Michael P. Keane, Cormac McCarthy
- Type 2 inflammation in chronic rhinosinusitis without nasal polyps: Another relevant endotype
- Tim Delemarre, Gabriele Holtappels, Natalie De Ruyck, Nan Zhang, Hans Nauwynck, Claus Bachert, Elien Gevaert
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?